Autoinhibition in Ras effectors Raf, PI3Kα, and RASSF5: a comprehensive review underscoring the challenges in pharmacological intervention
Open Access
- 29 September 2018
- journal article
- review article
- Published by Springer Science and Business Media LLC in Biophysical Reviews
- Vol. 10 (5), 1263-1282
- https://doi.org/10.1007/s12551-018-0461-0
Abstract
Autoinhibition is an effective mechanism that guards proteins against spurious activation. Despite its ubiquity, the distinct organizations of the autoinhibited states and their release mechanisms differ. Signaling is most responsive to the cell environment only if a small shift in the equilibrium is required to switch the system from an inactive (occluded) to an active (exposed) state. Ras signaling follows this paradigm. This underscores the challenge in pharmacological intervention to exploit and enhance autoinhibited states. Here, we review autoinhibition and release mechanisms at the membrane focusing on three representative Ras effectors, Raf protein kinase, PI3Kα lipid kinase, and NORE1A (RASSF5) tumor suppressor, and point to the ramifications to drug discovery. We further touch on Ras upstream and downstream signaling, Ras activation, and the Ras superfamily in this light, altogether providing a broad outlook of the principles and complexities of autoinhibition.Keywords
This publication has 159 references indexed in Scilit:
- Allo-network drugs: harnessing allostery in cellular networksTrends in Pharmacological Sciences, 2011
- Dynamic Allostery: Linkers Are Not Merely FlexibleStructure, 2011
- SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlationsHuman Mutation, 2011
- The Origin of Allosteric Functional Modulation: Multiple Pre-existing PathwaysStructure, 2009
- The Hypervariable Region of K-Ras4B Is Responsible for Its Specific Interactions with CalmodulinBiochemistry, 2009
- IQGAPs in cancer: A family of scaffold proteins underlying tumorigenesisFEBS Letters, 2009
- Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch IIThe EMBO Journal, 2008
- Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndromeNature Genetics, 2006
- Structural Evidence for Feedback Activation by Ras·GTP of the Ras-Specific Nucleotide Exchange Factor SOSCell, 2003
- EGF Activates Its Receptor by Removing Interactions that Autoinhibit Ectodomain DimerizationMolecular Cell, 2003